Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PE-TRACT: Catheter-Directed Therapy vs Anticoagulation Alone in Submassive Pulmonary Embolism
NCT05591118Phase 3Active, not recruiting
- Sponsor
- NYU Langone Health
- Start
- Jul 2023
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in pulmonary embolism (PE) (2 arms), sponsored by NYU Langone Health. Primary endpoints: Peak Oxygen Consumption at 3 months, New York Heart Association Functional Classification at 12 months and 1 more. Started Jul 2023; status: active, not recruiting.
02
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT05591118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05591118.